Mirzotamab

MedChem Express

Mirzotamab

10

Research Use Only

Monoclonal

99.45

Mirzotamab is an IgG1kappa monoclonal antibody targeting to CD276/B7-H3 with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate ( ADC ) [1] [2] [3] .

-80°C

12352203